Atlas Trials

Pilot Study Using an NMDA Antagonist to Modulate Transcranial Direct Current Stimulation (tDCS) Effects on Sensory Discrimination

Clinical trial NCT02426983 · UNKNOWN

Trial details

NCT number
NCT02426983
Sponsor
University of Ottawa
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Schizophrenia
Start date
2015-04-01
Primary completion
2015-09-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.